Market revenue in 2023 | USD 181.6 million |
Market revenue in 2030 | USD 303.6 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Regulatory writing & publishing |
Fastest growing segment | Legal Representation |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services |
Key market players worldwide | Genpact Ltd, Icon PLC, Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Labcorp Drug Development, Cencora Inc, Pharmexon, QVigilance, Voisin Consulting Life Sciences, Accell, Criterium Inc., Freyr Solutions, PharmaLex, NDA Regulatory Service GmbH, BlueReg Group, Cambridge Regulatory Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical regulatory affairs market will help companies and investors design strategic landscapes.
Regulatory writing & publishing was the largest segment with a revenue share of 31.5% in 2023. Horizon Databook has segmented the Latin America biopharmaceutical regulatory affairs market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is one of the fastest growing regions for pharmaceutical regulatory affairs market, followed by Asia Pacific. Growth in the region is due to the cost-effectiveness, increasing number of clinical trials, and rising number of new entrants venturing into the pharmaceutical market.
Furthermore, Brazil, Mexico, Venezuela, and Argentina are driving the growth in Latin America life sciences market. The market is expected to showcase significant growth during the forecast period owing to the increasing number of biopharmaceutical companies venturing into this region.
In addition, its geographic placement, in being strategically close to the U.S. market, is another factor attracting outsourcing in this region. The presence of CROs and regulatory service providers is also expected to increase considerably, which is further driving the growth of pharmaceutical regulatory affairs market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biopharmaceutical regulatory affairs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biopharmaceutical regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account